. Anonyme, Paludisme: un nouveau départ Consulté le 1/02/06 3: Malaria in Africa Consulté le 9110/05 [6] The Global Fund Economie costs of malaria The economic burden of malaria, Consulté le 9110105. [8] Gallup JL, Sachs DJ, pp.85-96, 2001.

J. Sachs and P. Malaney, The economic and social burden of malaria, Nature, vol.415, issue.6872, pp.680-685, 2002.
DOI : 10.1038/415680a

P. Malaney, A. Spielman, and J. Sachs, The malaria gap, Am J Trop Med Hyg, vol.71, pp.141-146, 2004.

T. Wellens and C. Plowe, Chloroquine???Resistant Malaria, The Journal of Infectious Diseases, vol.184, issue.6, pp.770-776, 2001.
DOI : 10.1086/322858

C. Wongsrichanalai, A. Pickard, W. Wernsdorfer, and S. Meshnick, Epidemiology of drug-resistant malaria, The Lancet Infectious Diseases, vol.2, issue.4, pp.209-218, 2002.
DOI : 10.1016/S1473-3099(02)00239-6

J. Maguire, I. Sumawinata, and S. Masbar, Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia, The Lancet, vol.360, issue.9326, pp.58-60, 2002.
DOI : 10.1016/S0140-6736(02)09336-4

P. Olliaro, W. Taylor, and J. Rigal, Controlling malaria: challenges and solutions, Tropical Medicine and International Health, vol.55, issue.11, pp.922-927, 2001.
DOI : 10.1016/S0140-6736(98)07367-X

F. Nosten, F. Ter-kuile, and T. Chongsuphajaisiddhi, Mefloquine-resistant falciparum malaria on the Thai-Burmese border, The Lancet, vol.337, issue.8750, pp.1140-1143, 1991.
DOI : 10.1016/0140-6736(91)92798-7

N. White, F. Nosten, and S. Looareesuwan, Averting a malaria disaster, The Lancet, vol.353, issue.9168, pp.1965-1967, 1999.
DOI : 10.1016/S0140-6736(98)07367-X

T. Jelinek, P. Schelbert, Y. Loscher, and D. Eichenlaub, Quinine resistant falciparum malaria acquired in east Africa, Trop Med Parasitol, vol.46, pp.38-40, 1995.

N. White, Antimalarial drug resistance, Journal of Clinical Investigation, vol.113, issue.8, pp.1084-1092, 2004.
DOI : 10.1172/JCI21682

P. Ambroise-thomas, Traitement du paludisme : prévenir les résistances par les associations d'antipaludiques, Med Trop, vol.60, pp.219-222, 2000.

N. White, Antimalarial drug resistance and combination chemotherapy, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.354, issue.1384, pp.739-749, 1999.
DOI : 10.1098/rstb.1999.0426

N. White, Assessment of the phannacodynamic properties of antimalarial drugs in vivo, AntimicrobAgents Chemother, vol.41, pp.1413-1422, 1997.

I. Hastings, A model for the origins and spread of drug-resistant malaria, Parasitology, vol.115, issue.2, pp.133-141, 1997.
DOI : 10.1017/S0031182097001261

I. Hastings, D. 'alessandro, and U. , Modelling a Predictable Disaster:, Parasitology Today, vol.16, issue.8, pp.340-347, 2000.
DOI : 10.1016/S0169-4758(00)01707-5

A. Talisuna, P. Langi, and N. Bakyaita, Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.96, issue.3, pp.310-317, 2002.
DOI : 10.1016/S0035-9203(02)90108-2

D. Payne, Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?, Parasitology Today, vol.4, issue.4, pp.112-115, 1988.
DOI : 10.1016/0169-4758(88)90042-7

I. Hastings, W. Watkins, and N. White, The evolution of drug-resistant malaria: the role of drug elimination half-life, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.357, issue.1420, pp.505-519, 2002.
DOI : 10.1098/rstb.2001.1036

P. Bloland, M. Ettling, and S. Meek, Combination therapy for malaria in Africa: hype or hope?, Bull World Health Organ, vol.78, pp.1378-1388, 2000.

F. Nosten and E. Ashley, The detection and treatment of Plasmodium falciparum malaria: Time for change, J Postgrad Med, vol.50, pp.35-39, 2004.

W. Wernsdorfer, Epidemiology of drug resistance in malaria, Acta Tropica, vol.56, issue.2-3, pp.143-156, 1994.
DOI : 10.1016/0001-706X(94)90060-4

R. Price, J. Simpson, and . Nosten, Factors contributing to anemia after uncomplicatedfalciparum malaria, Am J Trop Med Hyg, vol.65, pp.614-622, 2001.

J. Trape, The public health impact of chloroquine resistance in Africa, Am J Trop Med Hyg, vol.64, pp.12-17, 2001.

S. Murphy and J. Breman, Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycaemia, and complications of pregnancy, Am J Trop Med Hyg, vol.64, pp.57-67, 2001.

A. Talisuna, P. Bloland, D. 'alessandro, and U. , History, Dynamics, and Public Health Importance of Malaria Parasite Resistance, Clinical Microbiology Reviews, vol.17, issue.1, pp.235-254, 2004.
DOI : 10.1128/CMR.17.1.235-254.2004

M. Warsame, W. Wernsdorfer, G. Huldt, and A. Bjorkman, An epidemic of Plasmodium falciparum malaria in Balcad, Somalia, and its causation, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.89, issue.2, pp.142-145, 1995.
DOI : 10.1016/0035-9203(95)90469-7

F. Nosten and P. Brasseur, Combination Therapy for Malaria, Drugs, vol.6, issue.11, pp.1315-1329, 2002.
DOI : 10.2165/00003495-200262090-00003

P. Sudre, J. Breman, D. Mcfarland, and J. Koplan, Treatment of Chioroquine-Resistant Malaria in African Children: A Cost-Effectiveness Analysis, International Journal of Epidemiology, vol.21, issue.1, pp.146-154, 1992.
DOI : 10.1093/ije/21.1.146

T. Hien and N. White, Qinghaosu, The Lancet, vol.341, issue.8845, pp.603-608, 1993.
DOI : 10.1016/0140-6736(93)90362-K

P. Bernard, Une plante chinoise contre le paludisme Le Monde, pp.24-25, 2005.

D. Vries, P. Dien, and T. , Clinical Pharmacology and Therapeutic Potential of Artemisinin and its Derivatives in the Treatment of Malaria, Drugs, vol.52, issue.6, pp.818-836, 1996.
DOI : 10.2165/00003495-199652060-00004

S. Meshnick, Artemisinin antimalarials: mechanisms of action and resistance, Med Trop, vol.58, pp.13-17, 1998.

P. Ambroise-thomas, Données actuelles sur de nouveaux antipaludiques majeurs : les dérivés de l'Artémisinine (Qinghaosu) Bull Acad Natle Med, pp.797-813, 1999.

S. Looareesuwan, Overview of clinical studies on artemisinin derivatives in Thailand, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.1, pp.9-11, 1994.
DOI : 10.1016/0035-9203(94)90462-6

M. Van-hensbroek, E. Onyiorah, and S. Jaffar, A Trial of Artemether or Quinine in Children with Cerebral Malaria, New England Journal of Medicine, vol.335, issue.2, pp.69-75, 1996.
DOI : 10.1056/NEJM199607113350201

T. Hien, N. Day, and N. Phu, A Controlled Trial of Artemether or Quinine in Vietnamese Adults with Severe Falciparum Malaria, New England Journal of Medicine, vol.335, issue.2, pp.76-83, 1996.
DOI : 10.1056/NEJM199607113350202

R. Price, F. Nosten, and C. Luxemburger, Effects of artemisinin derivatives on malaria transmissibility, The Lancet, vol.347, issue.9016, pp.1654-1658, 1996.
DOI : 10.1016/S0140-6736(96)91488-9

M. Adjuik, A. Babiker, P. Garner, P. Olliaro, W. Taylor et al., International Artemisinin Study Group Artesunate combinations for treatment of malaria: metaanalysis, Lance!, vol.363, pp.9-17, 2004.

F. Nosten, M. Van-vugt, and P. Retal, Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study, The Lancet, vol.356, issue.9226, pp.297-302, 2000.
DOI : 10.1016/S0140-6736(00)02505-8

A. Eka, K. Banek, and N. Bakyaita, Artemisinin versus Nonartemisinin Combination Therapy for Uncomplicated Malaria: Randomized Clinical Trials from Four Sites in Uganda, PLoS Medicine, vol.68, issue.7, p.190, 2005.
DOI : 10.1371/journal.pmed.0020190.sd002

K. Barnes, D. Durrheim, and F. Little, Effect of Artemether-Lumefantrine Policy and Improved Vector Control on Malaria Burden in KwaZulu???Natal, South Africa, PLoS Medicine, vol.9, issue.11, p.330, 2005.
DOI : 10.1371/journal.pmed.0020330.t001

V. Navaratnam, S. Mansor, N. Sit, J. Grace, Q. Li et al., Pharmacokinetics of Artemisinin-Type Compounds, Clinical Pharmacokinetics, vol.40, issue.4, pp.255-270, 2000.
DOI : 10.2165/00003088-200039040-00002

K. Na-bangchang, S. Krudsood, and U. Silachamroon, The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers, Southeast Asian J Trop Med Public Health, vol.54, issue.35, pp.575-582, 2004.

K. Ilett, K. Batty, and S. Powelle, The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria, British Journal of Clinical Pharmacology, vol.43, issue.Suppl 1, pp.23-30, 2002.
DOI : 10.1046/j.0306-5251.2001.01519.x

. Anonyme, http: //www.dafra.be/fr/products.php . Produits finis de type antipaludique

J. Bouchez, S. Krudsood, P. Wilairatana, and S. Vannaphan, Fichier récapitulatif des différents dérivés de l'artémisinine présents sur le marché africain. Document Sanofi-Aventis/Impact Malaria Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand, Southeast Asian J Trop Med Public Health, vol.34, pp.54-61, 2003.

J. Karbwang, K. Na-bangchang, K. Congpuong, P. Molunto, and A. Thanavibul, Pharmacokinetics and bioavailability of oral and intramuscular artemether, European Journal of Clinical Pharmacology, vol.52, issue.4, pp.307-338, 1997.
DOI : 10.1007/s002280050295

T. Hien, T. Davis, and L. Chuong, Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria, Antimicrobial Agents and Chemotherapy, vol.48, issue.11, pp.4234-4239, 2004.
DOI : 10.1128/AAC.48.11.4234-4239.2004

L. Von-seidlein, S. Jaffar, and M. Pinder, Treatment of African Children with Uncomplicated Falciparum Malaria with a New Antimalarial Drug, CGP 56697, Les associations thérapeutiques à base d 'artémisinine : place dans le traitement du paludisme en Afi"ique (62), pp.1113-1116, 1997.
DOI : 10.1086/516524

P. Ambroise-thomas, The rational use of qinghaosu and its derivatives in the treatment of malaria in 1998, Med Trop, vol.58, issue.3, pp.6-8, 1998.

R. Price, M. Van-vugt, and L. Phaipun, Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives, Am J Trop Med Hyg, vol.60, issue.65, pp.547-555, 1999.

T. Brewer, S. Grate, and J. Peggins, Fatal neurotoxicity of arteether and artemether, Am J Trop Med Hyg, vol.51, pp.251-259, 1994.

A. Nontprasert, S. Pukrittayakamee, M. Nosten-bertrand, S. Vanijanonta, and N. White, Studies of the neurotoxicity of oral artemisinin derivatives in mice, Am J Trop Med Hyg, vol.62, pp.409-412, 2000.

M. Gready, R. Cho, T. Cho, and J. , Artemisinin derivatives in the treatment of falciparum malaria in pregnancy, Trans R Soc Trop Med Hyg, vol.92, pp.430-433, 1998.

N. White, Delaying antimalarial drug resistance with combination chemotherapy, Parassitologia, vol.41, pp.301-308, 1999.

N. White, Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 1998.
DOI : 10.1016/S1368-7646(98)80208-2

M. Danis and F. Bricaire, The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria, Fundamental and Clinical Pharmacology, vol.17, issue.2, pp.155-160, 2003.
DOI : 10.1046/j.1472-8206.2003.00165.x

R. Price, F. Nosten, and C. Luxemburger, Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.91, issue.5, pp.574-577, 1997.
DOI : 10.1016/S0035-9203(97)90032-8

. Anonyme, Novartis lauches international education program to ensure effective treatment with its fixed dose combination anti-malarial drug product, consisting of artemether and lumefantrine (Coartem®), com . Media realease, 2003.

N. Horton and . Http, Novaitis renforce les capacité de production de Coartem® pour fournir un médicament susceptible de sauver un plus grand nombre de patients, novartis.com. Communiqué du 22, 2004.

S. Looareesuwan, P. Wilairatana, and W. Chokejindachai, A randomized, doubleblind , comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand, Am J Trop Med Hyg, vol.60, pp.238-243, 1999.

M. Van-vugt, A. Brockman, and B. Gemperli, Randomized comparison of artemetherbenflumetol and artesunate-mefloquine in treatement of multidrug-resistant falciparum malaria, Antimicrob Agents Chemother, vol.42, pp.135-139, 1998.

G. Lefèvre, S. Looaresuwan, and S. Treeprasertsuk, A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand, Am J Trop Med Hyg, vol.64, pp.247-256, 2001.

M. Van-vugt, P. Wilairatana, and B. Gemperli, Efficacy of six doses of artemetherlumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria, Am J Trop Med Hyg, vol.60, pp.936-942, 1999.

C. Hertz, S. Abdulla, and R. Mull, Efficacy and safety of CGP 56697 ( artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years, Trop Med Jnt Health, vol.3, pp.498-504, 1998.

L. Von-seidlein, K. Bojang, and P. Jones, A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicatedfalciparum malaria in African children, Am J Trop Med Hyg, vol.58, pp.638-644, 1998.

N. White, M. Van-vugt, and F. Ezzet, Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine, Clinical Pharmacokinetics, vol.37, issue.2, pp.105-125, 1999.
DOI : 10.2165/00003088-199937020-00002

R. Bakshi, . Hermeling-fritz-1, . Gathmann, and E. Alteri, An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.4, pp.419-424, 2000.
DOI : 10.1016/S0035-9203(00)90126-3

M. Van-vugt, F. Ezzet, and F. Nosten, No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine, Am J Trop Med Hyg, vol.61, pp.964-967, 1999.

. Anonyme, dndi.org/press dossierO l.asp. Press dossier Combination therapy in global strategy for treatment of malaria, 2005.

A. Sowunmi, F. Fehintola, and A. Adedeji, Open randomized study of a1tesunate- amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodiumfalciparum malaria in Nigerian children, Trop Med lnt Health, vol.87, issue.10, pp.1161-1170, 2005.

M. Adjuik, P. Agnamey, and A. Babiker, Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial, The Lancet, vol.359, issue.9315, pp.1365-1372, 2002.
DOI : 10.1016/S0140-6736(02)08348-4

G. Priotto, J. Kabakyenga, and L. Pinoges, Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.97, issue.3, pp.325-330, 2003.
DOI : 10.1016/S0035-9203(03)90161-1

L. Von-seidlein, M. Jawara, R. Coleman, R. Doherty, G. Walrawen et al., Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria, Tropical Medicine and International Health, vol.1, issue.2, pp.92-98, 2001.
DOI : 10.1046/j.1365-3156.1999.00471.x

L. Von-seidlein, P. Milligan, and M. Pinder, Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial, The Lancet, vol.355, issue.9201, pp.352-357, 2000.
DOI : 10.1016/S0140-6736(99)10237-X

R. Amsalu and M. Balasegaram, Efficacy of two artem1smm combination therapies for uncomplicated falciparum malaria in children under 5 years, p.14

F. Nosten, C. Luxemburger, and F. Ter-kuile, Treatment Of Multidrug-Resistant Plasmodium Falciparum Malaria With 3-Day Artesunate-Mefloquine Combination, Journal of Infectious Diseases, vol.170, issue.4, pp.971-977, 1994.
DOI : 10.1093/infdis/170.4.971

A. Brockman, R. Price, and M. Van-vugt, Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.5, pp.537-544, 2000.
DOI : 10.1016/S0035-9203(00)90080-4

C. Sutherland, C. Drakeley, and U. Obisike, The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure, Am J Trop Med Hyg, vol.69, pp.19-25, 2003.

V. Gil, M. Ferreira, and F. Alva, Efficacy of artesunate plus chloroquine for uncomplicated malaria in children in Sao Tome and Principe: A double-blind, randomized, controlled trial, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.97, issue.6, pp.703-706, 2003.
DOI : 10.1016/S0035-9203(03)80107-4

M. Denis, T. Davis, and S. Hewitt, Efficacy and Safety of Dihydroartemisinin???Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum Malaria, Clinical Infectious Diseases, vol.35, issue.12, pp.1469-1476, 2002.
DOI : 10.1086/344647

T. Tran, C. Dolecek, and P. Pham, Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial, Lancet, vol.363, pp.18-22, 2004.

P. Giao, P. De-vries, H. L. , Q. Binh, T. Nam et al., CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam, Tropical Medicine and International Health, vol.17, issue.2, pp.209-216, 2004.
DOI : 10.1098/rstb.1999.0426

P. Ringwald, J. Bickii, and L. Basco, Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa, The Lancet, vol.347, issue.8993, pp.24-28, 1996.
DOI : 10.1016/S0140-6736(96)91558-5

P. Ollario and W. Taylor, Developing artemisinin based drug combinations for the treatment of drug resistantfalciparum malaria: A review, J Postgrad Med, vol.50, pp.40-44, 2004.

R. Snow, E. Eckert, and A. Teklehaimanot, Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa, Trends in Parasitology, vol.19, issue.8, pp.363-369, 2003.
DOI : 10.1016/S1471-4922(03)00168-5

M. Http, Briefing paper: Médicaments antipaludiques en rupture de stock, où sont les responsabilités?, msf.ch : Communiqué du 22

V. Wiseman, . Onwujekwe-0, F. Matovu, T. Mutabingwa, and C. Whitty, Differences in willingness to pay for artemisinin-based combinations or monotherapy: experience from the United Republic of Tanzania, Bull World Health Organ, vol.83, pp.845-852, 2005.

C. Muheki, M. Intyre, D. Barnes, and K. , Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa, Tropical Medicine and International Health, vol.363, issue.9, pp.959-966, 2004.
DOI : 10.1016/S1471-4922(02)02373-5

T. Shwe, M. Lwin, and S. Aung, Influence of blister packaging on the efficacy of artesunate+mefloquine over artesunate alone in community-based treatment of nonsevere falciparum malaria in Myanmar, Bull World Health Organ, vol.76, issue.1, pp.35-41, 1998.

S. Mccombie, Treatment seeking for malaria: A review of recent research, Social Science & Medicine, vol.43, issue.6, pp.933-945, 1996.
DOI : 10.1016/0277-9536(95)00446-7

. Muller-0, C. Traore, H. Becher, and B. Kouyate, Malaria morbidity, treatment-seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso, Tropical Medicine and International Health, vol.94, issue.4, pp.290-296, 2003.
DOI : 10.1016/S0277-9536(97)00195-0

S. Foster, Pricing, distribution, and use of antimalarial drugs, Bull World Health Organ, vol.69, pp.349-363, 1991.

S. Yeug, W. Pongtavornpinyo, I. Hastings, A. Mills, and N. White, Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modelling to elucidating policy choices, Am J Trop Med Hyg, vol.71, issue.2, pp.179-186, 2004.

N. Horton and . Http, Novartis partners with East African Botanicals to expand cultivation and extraction of natural ingredient used in anti-malarial Coartem®, novartis.com. Media release, 06, p.5

F. Nafo-traoré and . Www, who.int/malaria/docs/newsletterl fr.pdf, Nouvelles RBM, issue.1

. Shakoor-0, R. Taylor, and R. Behrens, Assessment of the incidence of substandard drugs in developing countries, Tropical Medicine and International Health, vol.2, issue.9, pp.839-845, 1997.
DOI : 10.1046/j.1365-3156.1997.d01-403.x

P. Newton, S. Proux, and M. Green, Fake artesunate in southeast Asia, The Lancet, vol.357, issue.9272, pp.1948-1950, 2001.
DOI : 10.1016/S0140-6736(00)05085-6